Home / ContractLibrary / Employment / Miscellany / Employment Offers

Employment Offers

Page 1 of 81 2 3 4 5 6 7 8

Preview Full Doc	2004	Letter Agreement Letter Agreement (5K) Doc #214414: Click preview link for longer preview. [Letterhead of Tenet Healthcare Corporation] Personal & Confidential January 30, 2004 Mr. Reynold Jennings 972 Acworth Due West Road Kennesaw, GA 30152 Dear Reynold: I am pleased to confirm the details of our offer to you to become Tenet's Chief Operating Officer (COO) with a start date on February 9, 2004. You will report to me, Chief Executive Officer. This letter will also serve to memorialize our understanding regarding your office location and the impact it has on any outstanding agreements between you and the company, specifically the TESPP. If you accept the offer to become Tenet's Chief Operating Officer, the COO's principal office will be in Dallas, TX. You will maintain an office in one of our Atlanta offices for convenience and occasional use, but it is your intention to spend roughly 40% to 60% of your time in Dallas, with the balance being spent in various regions and hospitals. Obviously this is only an estimate, and will vary depending on the circumstances and necessities of the position. You will not be required to move your residence to Dallas, as it is our intention that your objective will be to groom a successor within the next three years who could, at that time or within one to two years thereafter, become the company's COO. It is my understanding that you agree that because this move does not require you to move your family to Dallas, it will not trigger the relocation "order to move" provision of the TESPP. Other than this one exception, you remain within the terms of the TESPP agreement agreed to between you and Tenet in March 2003. Finally, in order to make the arrangement tax efficient for you and the company, we may continue to designate Atlanta as your primary office and Dallas as a secondary office. The following page sets forth the detailed terms being offered to you should you accept the position of Tenet's Chief Operating Officer. 214414	Tenet Healthcare Tenet Healthcare Corp. ( Healthcare Facilities ) As referenced in this Letter Agreement: tenet healthcare – e=toc_ke1103_1> Exhibit 10(i) [Letterhead of Tenet Healthcare Corporation] Personal & Confidential January 30, 2004 Mr. Reynold Jennings 972 Acworth tenet healthcare – a resolution of any grievance that results from your employment or termination of employment with Tenet Healthcare Corporation. Finally, your employment with the company will be on an at-will basis which dt 14144 ;	Reynold Jennings
Preview Full Doc	2004	Letter Agreement Letter Agreement (5K) Doc #214415: Click preview link for longer preview. [Letterhead of Tenet Healthcare Corporation] Personal & Confidential Sent via email December 22, 2003 Mr. Peter Urbanowicz, Jr. 2721 Poplar Street, NW Washington, DC 20007 Dear Peter: I am pleased to confirm the details of our offer to you to become Tenet's General Counsel with a start date of December 22, 2003. You will report to Trevor Fetter, Chief Executive Officer, and your principal office will be in Santa Barbara, California. 1. Compensation and Benefits: a. Base Compensation: Your starting base salary rate will be $450,000 per year, payable bi-weekly. Your next salary review will be April 1, 2005. b. Annual Incentive Plan: Your target award percentage in Tenet's Annual Incentive Plan (AIP) will be 60% of salary. The AIP is a function of exceptional individual and company performance. You will be eligible for a bonus for calendar year 2004. 214415	Tenet Healthcare Tenet Healthcare Corp. ( Healthcare Facilities ) As referenced in this Letter Agreement: tenet healthcare – e=toc_kn1103_1> Exhibit 10(k) [Letterhead of Tenet Healthcare Corporation] Personal & Confidential Sent via email December 22, 2003 Mr. Peter tenet healthcare – a resolution of any grievance that results from your employment or termination of employment with Tenet Healthcare Corporation. Finally, your employment with the company will be on an at-will basis which dt 14145 ;	Peter Urbanowicz, Jr.
Preview Full Doc	2004	Letter Agreement Re: Offer of Employment Letter Agreement Re: Offer of Employment (8K) Doc #230684: Click preview link for longer preview. [CABOT MICROELECTRONICS LOGO] November 2, 2003 Mr. William P. Noglows 204 Ocean Avenue Marblehead, MA 01945 Re: Offer of Employment Dear Bill: We are all very excited about your interest in Cabot Microelectronics Corporation ("CMC") and the prospects for a great future for CMC under your leadership. Accordingly, we are offering employment to you on the following terms: 1. Position. You would become CMC's Chairman, President and Chief Executive Officer, reporting to the Board of Directors of CMC. 2. Employment Date. Your first date of employment ("Employment Date") is tentatively planned for November 3, 2003. 3. Change in Control Agreement. CMC also will offer you a Change in Control Severance Protection Agreement that includes payment for three times salary and bonus and three years of certain benefits coverage and vesting of options with terms similar to the agreements CMC provides to other senior executive officers, including a gross-up provision in the event that penalty tax is assessed as a result of a payment. 4. Annual Salary. Your annual base salary would be $450,000. Following the close of each fiscal year, beginning with the end of Fiscal Year 2004, the Compensation Committee of the Board will meet to consider an increase in your annual base salary in accordance with its normal practices. CMC will pay your base salary in accordance with its normal payroll practices. 230684	Cabot Micro. Cabot Microelectronics Corp. ( Chemical Manufacturing ) As referenced in this Letter Agreement Re: Offer of Employment: [CABOT MICROELECTRONICS – c82790exv10w38.txt {DESCRIPTION}EMPLOYMENT OFFER LETTER DATED 2/2/03 {TEXT} {PAGE} EXHIBIT 10.38 [CABOT MICROELECTRONICS LOGO] November 2, 2003 Mr. William P. Noglows 204 Ocean Avenue Marblehead, MA 01945 Re: Cabot Microelectronics – Re: Offer of Employment Dear Bill: We are all very excited about your interest in Cabot Microelectronics Corporation ("CMC") and the prospects for a great future for CMC under your leadership. Cabot Microelectronics – of CMC's common stock (the "Initial Option") in accordance with the terms of the Cabot Microelectronics Corporation Amended and Restated 2000 Equity Incentive Plan. The grant date of the Initial Option dt 29968
Preview Full Doc	2004	Letter Agreement Letter Agreement (3K) Doc #241143: Click preview link for longer preview. {DOCUMENT} {TYPE}EX-10.9 {SEQUENCE}4 {FILENAME}h12046exv10w9.txt {DESCRIPTION}LETTER AGREEMENT - ANTHONY J. NOCELLA {TEXT} {PAGE} EXHIBIT 10.9 December 23, 2003 Mr. Anthony J. Nocella 9800 Richmond Avenue Suite 680 Houston, Texas 77042 Dear Tony: This letter shall serve as a conditional offer of employment to you by Franklin 241143	Franklin Franklin Bank Corp. ( S&Ls/Savings Banks ) As referenced in this Letter Agreement: Franklin Bank Corp. – 9800 Richmond Avenue Suite 680 Houston, Texas 77042 Dear Tony: This letter shall serve as a conditional offer of employment to you by Franklin Bank S.S.B ("Franklin") and Franklin Bank Corp. This offer is conditional upon the happening of the initial public offering of Franklin Bank Corp (the "IPO"). Thus, if you accept this offer and the IPO occurs, this _____________ Franklin Bank Corp – conditional offer of employment to you by Franklin Bank S.S.B ("Franklin") and Franklin Bank Corp. This offer is conditional upon the happening of the initial public offering of Franklin Bank Corp (the "IPO"). Thus, if you accept this offer and the IPO occurs, this letter agreement will take effect and supersede the prior letter agreement between you and by Franklin _____________ Franklin Bank Corp. – you will participate in Franklin's bonus program with a 2004 target of $150,000. Restricted Stock: In connection with the IPO, you will receive shares of restricted stock of Franklin Bank Corp. as set forth in a separate restricted stock award agreement Expenses: You will receive annual allowances as follows: auto -- $8,000, club dues $10,000, and executive physical examination _____________ Franklin Bank Corp. – period of time. You will be at all times an employee at will. Please also note that this offer, and the above particulars, are subject to Franklin's policies, any Franklin Bank Corp. Board of Directors' resolution or directive regarding the same and the approval of Franklin Bank Corp.'s Board of Directors. Please confirm your acceptance of this offer of employment _____________ Franklin Bank Corp. – that this offer, and the above particulars, are subject to Franklin's policies, any Franklin Bank Corp. Board of Directors' resolution or directive regarding the same and the approval of Franklin Bank Corp. 's Board of Directors. Please confirm your acceptance of this offer of employment by signing this letter where indicated and returning the executed original to our offices. Should you _____________ dt 1492124
Preview Full Doc	2004	Letter Agreement Letter Agreement (3K) Doc #241144: Click preview link for longer preview. {DOCUMENT} {TYPE}EX-10.10 {SEQUENCE}5 {FILENAME}h12046exv10w10.txt {DESCRIPTION}LETTER AGREEMENT - DANIEL E. COOPER {TEXT} {PAGE} EXHIBIT 10.10 December 23, 2003 Mr. Daniel Cooper 9800 Richmond Avenue Suite 680 Houston, Texas 77042 Dear Dan: This letter shall serve as a conditional offer of employment to you by Franklin 241144	Franklin Franklin Bank Corp. ( S&Ls/Savings Banks ) As referenced in this Letter Agreement: Franklin Bank Corp. – 9800 Richmond Avenue Suite 680 Houston, Texas 77042 Dear Dan: This letter shall serve as a conditional offer of employment to you by Franklin Bank S.S.B ("Franklin") and Franklin Bank Corp. This offer is conditional upon the happening of the initial public offering of Franklin Bank Corp (the "IPO"). Thus, if you accept this offer and the IPO occurs, this _____________ Franklin Bank Corp – conditional offer of employment to you by Franklin Bank S.S.B ("Franklin") and Franklin Bank Corp. This offer is conditional upon the happening of the initial public offering of Franklin Bank Corp (the "IPO"). Thus, if you accept this offer and the IPO occurs, this letter agreement will take effect and supersede the prior letter agreement between you and by Franklin _____________ Franklin Bank Corp. – you will participate in Franklin's bonus program with a 2004 target of $75,000. Restricted Stock: In connection with the IPO, you will receive shares of restricted stock of Franklin Bank Corp. as set forth in a separate restricted stock award agreement Expenses: You will receive annual allowances as follows: auto -- $8,000, and club dues $5,000. Severance: Generally, you _____________ Franklin Bank Corp. – of time. You will be at all times an employee at will. {PAGE} Please also note that this offer, and the above particulars, are subject to Franklin's policies, any Franklin Bank Corp. Board of Directors' resolution or directive regarding the same and the approval of Franklin Bank Corp.'s Board of Directors. Please confirm your acceptance of this offer of employment _____________ Franklin Bank Corp. – that this offer, and the above particulars, are subject to Franklin's policies, any Franklin Bank Corp. Board of Directors' resolution or directive regarding the same and the approval of Franklin Bank Corp. 's Board of Directors. Please confirm your acceptance of this offer of employment by signing this letter where indicated and returning the executed original to our offices. Should you _____________ dt 1492125
Preview Full Doc	2004	Letter Agreement Letter Agreement (3K) Doc #241145: Click preview link for longer preview. {DOCUMENT} {TYPE}EX-10.11 {SEQUENCE}6 {FILENAME}h12046exv10w11.txt {DESCRIPTION}LETTER AGREEMENT - GLENN MEALEY {TEXT} {PAGE} EXHIBIT 10.11 December 23, 2003 Mr. Glenn Mealey 9800 Richmond Avenue Suite 680 Houston, Texas 77042 Dear Glenn: This letter shall serve as a conditional offer of employment to you by Franklin 241145	Franklin Franklin Bank Corp. ( S&Ls/Savings Banks ) As referenced in this Letter Agreement: Franklin Bank Corp. – 9800 Richmond Avenue Suite 680 Houston, Texas 77042 Dear Glenn: This letter shall serve as a conditional offer of employment to you by Franklin Bank S.S.B ("Franklin") and Franklin Bank Corp. This offer is conditional upon the happening of the initial public offering of Franklin Bank Corp (the "IPO"). Thus, if you accept this offer and the IPO occurs, this _____________ Franklin Bank Corp – conditional offer of employment to you by Franklin Bank S.S.B ("Franklin") and Franklin Bank Corp. This offer is conditional upon the happening of the initial public offering of Franklin Bank Corp (the "IPO"). Thus, if you accept this offer and the IPO occurs, this letter agreement will take effect and supersede the prior letter agreement between you and by Franklin _____________ Franklin Bank Corp. – you will participate in Franklin's bonus program with a 2004 target of $75,000. Restricted Stock: In connection with the IPO, you will receive shares of restricted stock of Franklin Bank Corp. as set forth in a separate restricted stock award agreement Expenses: You will receive annual allowances as follows: auto -- $8,000 and club dues $5,000. Severance: Generally, you _____________ Franklin Bank Corp. – of time. You will be at all times an employee at will. {PAGE} Please also note that this offer, and the above particulars, are subject to Franklin's policies, any Franklin Bank Corp. Board of Directors' resolution or directive regarding the same and the approval of Franklin Bank Corp.'s Board of Directors. Please confirm your acceptance of this offer of employment _____________ Franklin Bank Corp. – that this offer, and the above particulars, are subject to Franklin's policies, any Franklin Bank Corp. Board of Directors' resolution or directive regarding the same and the approval of Franklin Bank Corp. 's Board of Directors. Please confirm your acceptance of this offer of employment by signing this letter where indicated and returning the executed original to our offices. Should you _____________ dt 1492126
Preview Full Doc	2004	Letter Agreement Letter Agreement (3K) Doc #241146: Click preview link for longer preview. {DOCUMENT} {TYPE}EX-10.12 {SEQUENCE}7 {FILENAME}h12046exv10w12.txt {DESCRIPTION}LETTER AGREEMENT - RUSSELL MCCANN {TEXT} {PAGE} EXHIBIT 10.12 December 23, 2003 Mr. Russell McCann 9800 Richmond Avenue Suite 680 Houston, Texas 77042 Dear Russell: This letter shall serve as a conditional offer of employment to you by Franklin 241146	Franklin Franklin Bank Corp. ( S&Ls/Savings Banks ) As referenced in this Letter Agreement: Franklin Bank Corp. – 9800 Richmond Avenue Suite 680 Houston, Texas 77042 Dear Russell: This letter shall serve as a conditional offer of employment to you by Franklin Bank S.S.B ("Franklin") and Franklin Bank Corp. This offer is conditional upon the happening of the initial public offering of Franklin Bank Corp (the "IPO"). Thus, if you accept this offer and the IPO occurs, this _____________ Franklin Bank Corp – conditional offer of employment to you by Franklin Bank S.S.B ("Franklin") and Franklin Bank Corp. This offer is conditional upon the happening of the initial public offering of Franklin Bank Corp (the "IPO"). Thus, if you accept this offer and the IPO occurs, this letter agreement will take effect and supersede the prior letter agreement between you and by Franklin _____________ Franklin Bank Corp. – you will participate in Franklin's bonus program with a 2004 target of $75,000. Restricted Stock: In connection with the IPO, you will receive shares of restricted stock of Franklin Bank Corp. as set forth in a separate restricted stock award agreement Expenses: You will receive annual allowances as follows: auto -- $8,000 and club dues $5,000. Severance: Generally, you _____________ Franklin Bank Corp. – of time. You will be at all times an employee at will. {PAGE} Please also note that this offer, and the above particulars, are subject to Franklin's policies, any Franklin Bank Corp. Board of Directors' resolution or directive regarding the same and the approval of Franklin Bank Corp.'s Board of Directors. Please confirm your acceptance of this offer of employment _____________ Franklin Bank Corp. – that this offer, and the above particulars, are subject to Franklin's policies, any Franklin Bank Corp. Board of Directors' resolution or directive regarding the same and the approval of Franklin Bank Corp. 's Board of Directors. Please confirm your acceptance of this offer of employment by signing this letter where indicated and returning the executed original to our offices. Should you _____________ dt 1492127
Preview Full Doc	2004	Letter Agreement Letter Agreement (3K) Doc #241147: Click preview link for longer preview. {DOCUMENT} {TYPE}EX-10.13 {SEQUENCE}8 {FILENAME}h12046exv10w13.txt {DESCRIPTION}LETTER AGREEMENT - MICHAEL DAVITT {TEXT} {PAGE} EXHIBIT 10.13 December 23, 2003 Mr. Michael Davitt 9800 Richmond Avenue Suite 680 Houston, Texas 77042 Dear Mike: This letter shall serve as a conditional offer of employment to you by Franklin 241147	Franklin Franklin Bank Corp. ( S&Ls/Savings Banks ) As referenced in this Letter Agreement: Franklin Bank Corp. – 9800 Richmond Avenue Suite 680 Houston, Texas 77042 Dear Mike: This letter shall serve as a conditional offer of employment to you by Franklin Bank S.S.B ("Franklin") and Franklin Bank Corp. This offer is conditional upon the happening of the initial public offering of Franklin Bank Corp (the "IPO"). Thus, if you accept this offer and the IPO occurs, this _____________ Franklin Bank Corp – conditional offer of employment to you by Franklin Bank S.S.B ("Franklin") and Franklin Bank Corp. This offer is conditional upon the happening of the initial public offering of Franklin Bank Corp (the "IPO"). Thus, if you accept this offer and the IPO occurs, this letter agreement will take effect and supersede the prior letter agreement between you and by Franklin _____________ Franklin Bank Corp. – you will participate in Franklin's bonus program with a 2004 target of $75,000. Restricted Stock: In connection with the IPO, you will receive shares of restricted stock of Franklin Bank Corp. as set forth in a separate restricted stock award agreement Expenses: You will receive annual allowances as follows: auto -- $8,000 and club dues $5,000. Severance: Generally, you _____________ Franklin Bank Corp. – of time. You will be at all times an employee at will. {PAGE} Please also note that this offer, and the above particulars, are subject to Franklin's policies, any Franklin Bank Corp. Board of Directors' resolution or directive regarding the same and the approval of Franklin Bank Corp.'s Board of Directors. Please confirm your acceptance of this offer of employment _____________ Franklin Bank Corp. – that this offer, and the above particulars, are subject to Franklin's policies, any Franklin Bank Corp. Board of Directors' resolution or directive regarding the same and the approval of Franklin Bank Corp. 's Board of Directors. Please confirm your acceptance of this offer of employment by signing this letter where indicated and returning the executed original to our offices. Should you _____________ dt 1492128
Preview Full Doc	2004	Letter Agreement Letter Agreement (13K) Doc #252031: Click preview link for longer preview. May 7, 2001 Mr. D. Michael Steuert 2956 Morvale Drive Thousand Oaks, CA 91361 Dear Michael, We are pleased to extend to you an offer of employment as Senior Vice President and Chief Financial Officer of Fluor Corporation. All of us that have had the opportunity to visit with you are confident that we will benefit from your years of experience and are sure that you will find Fluor Corporation a challenging and enjoyable environment in which to work. We will work with you to determine a mutually agreeable start date. SALARY Your starting salary will be $500,000 annually. ANNUAL INCENTIVE As a member of the Executive Management Team you will be in a "must review" category for annual incentive consideration each year based upon your individual performance as well as the performance of the Corporation. Your target incentive amount is 65% of your base salary or $325,000, and you will have the potential to earn from zero to twice this amount based on your individual performance and the overall results of the corporation. Our fiscal year is January 1st through December 31st, with incentives paid the following March. Your first year bonus will be prorated based on actual months worked. NEW HIRE AWARD We will recommend to the Organization and Compensation Committee of Fluor Corporation that we provide you the following awards: LTI CASH 2001 - 2003 PROGRAM You will be recommended for participation in the current LTI cash program covering FY 2001-2003 with a three-year targeted cash award of $300,000. Performance objectives for the cash portion of this three-year program will be established each fiscal year. At the end of each fiscal year, the Organization and Compensation Committee will evaluate the performance results of Fluor Corporation. If the objectives are achieved a payout with a performance rating of 0 to 2 times will be paid to you based on one-third of your target cash award ($100,000) each year. Initialed__________ 252031	Fluor Fluor Corp. ( Construction ) ;	D. Michael Steuert
Preview Full Doc	2004	Letter Agreement Letter Agreement (12K) Doc #254257: Click preview link for longer preview. HEIDRICK & STRUGGLES Consultants in Executive Search May 4, 1993 Michael T. Christy Partner Ms. Joie A Gregor 702 Gates Road Gates Mill, Ohio 44040 Dear Joie: I am pleased to confirm Heidrick & Struggles, Inc.s offer of employment to you. We are looking forward to your arrival and want to set forth our understanding: 1. You will join our Tysons Corner (Vienna, Virginia) Office with the title of Partner at a monthly base salary of $12,500.00 (which is $150,000.00 annually), commencing on your first day of employment, which shall be June 1, 1993. Currently, salaries are reviewed annually in March, so that your first salary review will be in March 1994. A copy of our Partner/Consultant Cash Compensation Policy is enclosed for your information. 2. You will first be eligible for a discretionary bonus for the year ending on December 31, 1993. You understand that, except for the minimum bonuses referred to below, all bonuses are discretionary and not earned until declared by the Board of Directors or the Executive Committee of the Board of Directors, and that all discretionary, incentive and/or minimum bonuses are payable only if you are in our employ on the bonus payment dates. As we discussed, you will be eligible to receive a minimum bonus for 1993 as follows: 1993 Minimum Bonus. Subject to the following conditions, you will receive a $182,000 minimum bonus for the calendar year ending December 31, 1993, payable as follows: (1) $35,000 payable on June 30, 1993; (2) $25,000 payable on September 30, 1993; (3) $122,000 payable at the time 1993 bonuses are paid in March 1994; provided, however, that the foregoing 1993 minimum bonus will be reduced by $.50 for each $1.00 that the sum of your June 1-December 31, 1993 fee and SOB credits is less than $773,000. You expect to achieve at least 254257	Heidrick Heidrick & Struggles International Inc. ( Business Services ) ;	Joie A. Gregor
Preview Full Doc	2004	Letter Agreement Letter Agreement (36K) Doc #272201: Click preview link for longer preview. [MEMORY COMPANY LOGO] MEMORY PHARMACEUTICALS CORP. JOANNE LEONARD 100 PHILIPS PARKWAY SENIOR VICE PRESIDENT MONTVALE, NEW JERSEY 07645 CHIEF FINANCIAL OFFICER PHONE: (201) 802-7102 FAX: (201) 802-7190 www.memorypharma.com February 18, 2002 James E. Barrett, Ph.D. 1231 River Road Washington Crossing, PA 18977 Dear Jim: We are pleased to extend an offer to you to join our Company as Senior Vice President of Research and Development. We look forward to you joining our team, and are confident that you will contribute significantly to the value of our organization. The terms of your anticipated employment by the Company are as follows. 1. Position. Your position will be Senior Vice President of Research and Development, based out of the Company's offices currently located in Montvale, New Jersey, and will report directly to the Company's President and Chief Scientific Officer. As Senior Vice President of Research and Development, you will be part of the Company's senior management team, and will work closely with this team to establish strategic, value-building relationships with pharmaceutical companies and contract research organizations. Your responsibilities shall include, but not be limited to, managing all research and development activities up to clinical Phase IIa studies and managing post collaboration interface on pivotal clinical trials. In addition to performing duties and responsibilities associated with the position of Senior Vice President of Research and Development, from time to time the Company may assign you other duties and responsibilities and/or may assign you to a different location. As a full-time employee of the Company, you will be expected to devote your full business time and energies to the business and affairs of the Company. Your performance will be reviewed formally after six months of employment and annually thereafter at the end of each calendar year. 2. Starting Date/Nature of Relationship. It is expected that your employment will start on April 16, 2002 (the "Start Date"). No provision of this letter shall be construed to create an express or implied employment contract for a specific period of time. Either you or the Company may terminate the employment relationship at any time and for any reason, by giving at least thirty (30) days' prior written notice to the other party. 3. Compensation. (a) Your initial salary will be at the bi-weekly rate of $10,576.92 (annualized at $275,000). (b) You will receive incentive stock options to purchase 300,000 Shares of Common Stock of Memory Pharmaceuticals Corp. at $0.25 per share, which will vest in quarterly increments over a period of four (4) years as described in the Stock Option Agreement, which you and the Company will enter into on or before the Start Date. You will receive additional incentive stock {PAGE} MEMORY PHARMACEUTICALS CORP. James E. Barrett, Ph.D. options to purchase Shares of Common Stock of Memory Pharmaceuticals Corp., immediately after the closing of the Company's Series D Financing at the then fair market value to be determined by the Company's Board of Directors (without affecting the purchase price of the initial grant of options to acquire 300,000 shares of the Company's Common Stock), with such additional option vesting to commence on the date of such grant in quarterly increments over a period of four (4) years. The additional incentive stock options to purchase Shares are being provided to allow your percentage ownership before the Series D Financing not to be substantially diluted. (c) You will be eligible to receive annual bonus payments dependent on the performance of the Company and your individual performance, subject to the discretion of the Board of Directors. Your target bonus will be equal to twenty-five percent (25%) of your base salary, assuming the achievement of such Company and individual performance objectives. You will receive a one-time annual guaranteed bonus of $25,000, payable within 30 days of your one-year anniversary. (d) Upon termination for any reason, the Company will pay you within two weeks of such termination, your current base salary earned through the termination date, plus accrued vacation, if any, and other benefits or payments, if any, to which you are entitled. In the event you are terminated by the Company, without "Cause" (as hereinafter defined), then the Company will continue to pay you your bi-weekly rate in effect at the time of termination and provide and pay the Company's portion of your medical insurance for a period of six (6) months. Further, for the period commencing seven months following such termination and ending twelve months after such termination, the Company will continue to pay you your bi-weekly rate in effect at the time of termination and provide and pay the Company's portion of your medical insurance, except that such severance payments made to you during this period will be reduced by all 1099 and W-2 income earned or received by you during such period, including income earned or received from consulting services or temporary employment, and the Company's payments for your medical insurance will terminate when you have such coverage through any new employer before the end of the twelve month period following your termination. The Company will reconcile such payments with you 272201	Memory Pharma Memory Pharmaceuticals Corp. ( Pharmaceutical Preparations ) As referenced in this Letter Agreement: MEMORY PHARMACEUTICALS CORP – {DOCUMENT} {TYPE}EX-10.19 {SEQUENCE}12 {FILENAME}y92465a2exv10w19.txt {DESCRIPTION}EMPLOYMENT LETTER AGREEMENT {TEXT} {PAGE} EXHIBIT 10.19 [MEMORY COMPANY LOGO] MEMORY PHARMACEUTICALS CORP . JOANNE LEONARD 100 PHILIPS PARKWAY SENIOR VICE PRESIDENT MONTVALE, NEW JERSEY 07645 CHIEF FINANCIAL OFFICER PHONE: (201) 802-7102 FAX: (201) 802- _____________ Memory Pharmaceuticals Corp – 10,576.92 (annualized at $275,000). (b) You will receive incentive stock options to purchase 300,000 Shares of Common Stock of Memory Pharmaceuticals Corp . at $0.25 per share, which will vest in quarterly increments over a period of four (4) years as described in the _____________ MEMORY PHARMACEUTICALS CORP – Option Agreement, which you and the Company will enter into on or before the Start Date. You will receive additional incentive stock {PAGE} MEMORY PHARMACEUTICALS CORP . James E. Barrett, Ph.D. options to purchase Shares of Common Stock of Memory Pharmaceuticals Corp., immediately after the closing of the _____________ Memory Pharmaceuticals Corp – You will receive additional incentive stock {PAGE} MEMORY PHARMACEUTICALS CORP. James E. Barrett, Ph.D. options to purchase Shares of Common Stock of Memory Pharmaceuticals Corp ., immediately after the closing of the Company's Series D Financing at the then fair market value to be determined by the _____________ MEMORY PHARMACEUTICALS CORP – its employees and executives generally. At this time, the Company is offering a benefit program, consisting of medical, dental, life and 2 {PAGE} MEMORY PHARMACEUTICALS CORP . James E. Barrett, Ph.D. short/long term disability insurance, as well as a 401(k) retirement plan and flexible spending plan. _____________ dt 181256
Preview Full Doc	2004	Letter Agreement Letter Agreement (36K) Doc #272202: Click preview link for longer preview. (MEMORY LOGO) MEMORY PHARMACEUTICALS CORP. JOANNE LEONARD 100 PHILIPS PARKWAY SENIOR VICE PRESIDENT MONTVALE, NEW JERSEY 07645 CHIEF FINANCIAL OFFICER PHONE: (201) 802-7102 FAX: (201) 802-7190 www.memorypharma.com December 14,2001 Gardiner F.H. Smith 7913 Brethren Drive Gaithersburg, MD 20879 Dear Gardiner: We are pleased to inform you that both the Board of Directors and management team of Memory Pharmaceuticals Corp. (the "Company") are impressed with your experience and accomplishments, and would like to extend an offer to you to join our Company as Vice President of Business Development. We look forward to you joining our team, and are confident that you will contribute significantly to the value of our organization. We are therefore pleased to provide you with the terms of your anticipated employment by the Company. 1. Position. Your position will be Vice President of Business Development, based out of the Company's offices currently located in Montvale, New Jersey, and will report directly to the Company's Chief Executive Officer. As Vice President of Business Development, you will be part of the Company's senior management team, and will work closely with this team to establish strategic, value-building relationships with pharmaceutical companies and academic institutions. Your responsibilities shall include, but not be limited to, securing and overseeing collaborations with corporate partners, in-licensing and out-licensing activities, management of intellectual property, and maintenance of a competitor intelligence information database. In addition to performing duties and responsibilities associated with the position of Vice President of Business Development, from time to time the Company may assign you other duties and responsibilities and/or may assign you to a different location. As a full-time employee of the Company, you will be expected to devote your full business time and energies to the business and affairs of the Company. Your performance will be reviewed formally after six months of employment and annually thereafter at the end of each calendar year. 2. Starting Date/Nature of Relationship. It is expected that your employment will start on January 21, 2002 (the "Start Date"). No provision of this letter shall be construed to create an express or implied employment contract for a specific period of time. Either you or the Company may terminate the employment relationship at any time and for any reason, by giving at least thirty (30) days' prior written notice to the other party. 3. Compensation. (a) Your initial salary will be at the bi-weekly rate of $7,500.00 (annualized at $195,000). (b) You will receive a one-time sign-on bonus of $25,000, payable within 30 days of your Start Date. This sign-on bonus is fully refundable to the Company if you leave the Company within twelve months of your Start Date. {PAGE} MEMORY PHARMACEUTICALS CORP. Gardiner F.H. Smith (c) You will receive incentive stock options to purchase 140,000 Shares of Common Stock of Memory Pharmaceuticals Corp. at $0.25 per share, which will vest in quarterly increments over a period of four (4) years as described in the Stock Option Agreement, which you and the Company will enter into on or before the Start Date. You will receive additional incentive stock options to purchase 135,000 Shares of Common Stock of Memory Pharmaceuticals Corp., immediately after the closing of the Company's Series D Financing at the then fair market value to be determined by the Company's Board of Directors (without affecting the purchase price of the initial grant of options to acquire 140,000 shares of the Company's Common Stock), with such additional option vesting to commence on the date of such grant in quarterly increments over a period of four (4) years. The additional incentive stock options to purchase 135,000 Shares are being provided to allow your percentage ownership before the Series D Financing not to be substantialty diluted. (d) You will be eligible to receive annual bonus payments dependent on the performance of the Company and your individual performance, subject to the discretion of the Board of Directors. Your target bonus will be equal to twenty-five percent (25%) of your base salary, assuming the achievement of such Company and individual performance objectives. (e) Upon termination for any reason, the Company will pay you within two weeks of such termination, your current base salary earned through the termination date, plus accrued vacation, if any, and other benefits or payments, if any, to which you are entitled. In the event you are terminated by the Company, without "Cause" (as hereinafter defined), then the Company will continue to pay you your bi-weekly rate in effect at the time of termination and provide and pay the Company's portion of your medical insurance for a period of six (6) months. Further, for the period commencing seven months following such termination and ending twelve months after such termination, the Company will continue to pay you your bi-weekly rate in effect at the time of termination and provide and pay the Company's portion of your medical insurance, except that such severance payments made to you during this period will be reduced by all 1099 and W-2 income earned or received by you during such period, including 272202	Memory Pharma Memory Pharmaceuticals Corp. ( Pharmaceutical Preparations ) As referenced in this Letter Agreement: MEMORY PHARMACEUTICALS CORP – {DOCUMENT} {TYPE}EX-10.20 {SEQUENCE}13 {FILENAME}y92465a2exv10w20.txt {DESCRIPTION}EMPLOYMENT LETTER AGREEMENT {TEXT} {PAGE} Exhibit 10.20 (MEMORY LOGO) MEMORY PHARMACEUTICALS CORP . JOANNE LEONARD 100 PHILIPS PARKWAY SENIOR VICE PRESIDENT MONTVALE, NEW JERSEY 07645 CHIEF FINANCIAL OFFICER PHONE: (201) 802-7102 FAX: (201) 802- _____________ Memory Pharmaceuticals Corp – Brethren Drive Gaithersburg, MD 20879 Dear Gardiner: We are pleased to inform you that both the Board of Directors and management team of Memory Pharmaceuticals Corp . (the "Company") are impressed with your experience and accomplishments, and would like to extend an offer to you to join our Company _____________ MEMORY PHARMACEUTICALS CORP – This sign-on bonus is fully refundable to the Company if you leave the Company within twelve months of your Start Date. {PAGE} MEMORY PHARMACEUTICALS CORP . Gardiner F.H. Smith (c) You will receive incentive stock options to purchase 140,000 Shares of Common Stock of Memory Pharmaceuticals _____________ Memory Pharmaceuticals Corp – MEMORY PHARMACEUTICALS CORP. Gardiner F.H. Smith (c) You will receive incentive stock options to purchase 140,000 Shares of Common Stock of Memory Pharmaceuticals Corp . at $0.25 per share, which will vest in quarterly increments over a period of four (4) years as described in the _____________ Memory Pharmaceuticals Corp – into on or before the Start Date. You will receive additional incentive stock options to purchase 135,000 Shares of Common Stock of Memory Pharmaceuticals Corp ., immediately after the closing of the Company's Series D Financing at the then fair market value to be determined by the _____________ dt 181257
Preview Full Doc	2004	Letter Agreement Letter Agreement (32K) Doc #272204: Click preview link for longer preview. [MEMORY PHARMACEUTICALS CORP. LOGO] MEMORY PHARMACEUTICALS CORP. Tony Scullion 100 Philips Parkway Chief Executive Officer Montvale, New Jersey 07645 Phone: (201) 802-7102 Fax: (201) 802-7190 www.memorypharma.com December 16, 2003 Mr. Dennis Keane 50 Constant Avenue Yonkers, NY 10701 Dear Dennis: We are pleased to inform you that both the Board of Directors and management team of Memory Pharmaceuticals Corp. (the "Company") are impressed with your experience and accomplishments, and would like to extend an offer to you to join our Company as Chief Financial Officer. We look forward to you joining our team, and are confident that you will contribute significantly to the value of our organization. We are therefore pleased to provide you with the terms of your anticipated employment by the Company. 1. Position. In your position of Chief Financial Officer you will initially report to the Company's Chief Executive Officer, based out of the Company's offices currently located in Montvale, New Jersey. As Chief Financial Officer, you will be part of the senior management team (comprising the senior executives of the Company), and your responsibilities shall include, but not be limited to, managing and directing the financial affairs of the Company. In addition to performing duties and responsibilities associated with the position of Chief Financial Officer, from time to time the Company may assign you other duties and responsibilities and/or may assign you to a different location within fifty (50) miles of the Company's principal office in Montvale, New Jersey. As a full-time employee of the Company, you will be expected to devote your full business time and energies to the business and affairs of the Company. Your performance will be reviewed formally after six months of employment and annually thereafter at the end of each calendar year. 2. Starting Date/Nature of Relationship. It is expected that your employment will start on January 6, 2004 (the "Start Date"). No provision of this letter shall be construed to create an express or implied employment contract for a specific period of time. Either you or the Company may terminate the employment relationship at any time and for any reason. 3. Compensation. (a) Your initial salary will be at the bi-weekly rate of $8,269.23 (annualized at $215,000 per year). (b) You will receive non-qualified stock options to purchase, at fair market value to be determined by the Company's Board of Directors (currently $0.90 per share), 300,000 Shares of Common Stock of Memory Pharmaceuticals Corp., which shall vest in quarterly increments over a period of four (4) years as described in the Stock Option Agreement, which you and the Company will enter into on or before the Start Date. {PAGE} (c) You will be eligible to receive annual bonus payments dependent on the performance of the Company and your individual performance, subject to the discretion of the Board of Directors. Your target bonus will be equal to twenty-five percent (25%) of your base salary, assuming the achievement of such Company and individual performance objectives. (d) Upon termination for any reason, the Company shall pay you within two weeks of such termination, your current base salary earned through the termination date, plus accrued vacation, if any, and other benefits or payments, if any, to which you are entitled. In the event you are terminated by the Company, without "Cause" (as hereinafter defined), then the Company shall continue to pay you your bi-weekly rate in effect at the time of termination and provide and pay the Company's portion of your medical insurance for a period of six months. Further, for the period commencing seven months following such termination and ending twelve months after such termination, the Company shall continue to pay you your bi-weekly rate in effect at the time of termination and provide and pay the Company's portion of your medical insurance, except that such severance payments made to you during this period shall be reduced by all 1099 and W-2 income earned or received by you during such period, including income earned or received from consulting services or temporary employment. The Company shall reconcile such payments with you quarterly, and any additional payments owed to you by the Company, and any payments owed to the Company by you, shall be paid respectively within two weeks following such reconciliation period. In addition, upon termination of your employment without "Cause," you will be entitled to accelerated vesting of your stock options as if your employment was terminated one year after your actual termination date. The Company shall not be obligated to continue any such payments to you or accelerate vesting of your stock options under this paragraph 3(e) in the event you materially breach the terms under the Confidentiality Agreement attached hereto. Notwithstanding any termination of your employment for any reason (with or without Cause), you shall continue to be bound by the provisions of the Confidentiality Agreement. (e) For the purposes of this Section 3, "Cause" shall include (i) your conviction of a felony, either in connection with the performance of your obligations to the Company or otherwise, which adversely affects your 272204	Memory Pharma Memory Pharmaceuticals Corp. ( Pharmaceutical Preparations ) As referenced in this Letter Agreement: [MEMORY PHARMACEUTICALS CORP – {DOCUMENT} {TYPE}EX-10.25 {SEQUENCE}15 {FILENAME}y92465a2exv10w25.txt {DESCRIPTION}EMPLOYMENT LETTER AGREEMENT {TEXT} {PAGE} EXHIBIT 10.25 [MEMORY PHARMACEUTICALS CORP . LOGO] MEMORY PHARMACEUTICALS CORP. Tony Scullion 100 Philips Parkway Chief Executive Officer Montvale, New Jersey 07645 Phone: (201) 802-7102 Fax: (201) _____________ MEMORY PHARMACEUTICALS CORP – DOCUMENT} {TYPE}EX-10.25 {SEQUENCE}15 {FILENAME}y92465a2exv10w25.txt {DESCRIPTION}EMPLOYMENT LETTER AGREEMENT {TEXT} {PAGE} EXHIBIT 10.25 [MEMORY PHARMACEUTICALS CORP. LOGO] MEMORY PHARMACEUTICALS CORP . Tony Scullion 100 Philips Parkway Chief Executive Officer Montvale, New Jersey 07645 Phone: (201) 802-7102 Fax: (201) 802-7190 www.memorypharma. _____________ Memory Pharmaceuticals Corp – Constant Avenue Yonkers, NY 10701 Dear Dennis: We are pleased to inform you that both the Board of Directors and management team of Memory Pharmaceuticals Corp . (the "Company") are impressed with your experience and accomplishments, and would like to extend an offer to you to join our Company _____________ Memory Pharmaceuticals Corp – value to be determined by the Company's Board of Directors (currently $0.90 per share), 300,000 Shares of Common Stock of Memory Pharmaceuticals Corp ., which shall vest in quarterly increments over a period of four (4) years as described in the Stock Option Agreement, which you _____________ MEMORY PHARMACEUTICALS CORP – you will make a significant contribution to the Company's growth. We look forward to your prompt response to this offer letter. Sincerely, MEMORY PHARMACEUTICALS CORP . By: /s/ Tony Scullion ---------------------- Name: Tony Scullion Title: Chief Executive Officer ACCEPTED AND AGREED: /s/ Dennis Keane -------------------------- Dennis Keane Date: 12/16/ _____________ dt 181259
Preview Full Doc	2004	Letter Agreement Letter Agreement (10K) Doc #272208: Click preview link for longer preview. [MEMORY PHARMACEUTICALS CORP. LOGO] MEMORY PHARMACEUTICALS CORP. Tony Scullion 100 Philips Parkway Chief Executive Officer Montvale, New Jersey 07645 Phone: (201) 802-7102 Fax: (201) 802-7190 www.memorypharma.com December 16, 2003 Mr. Dennis Keane 50 Constant Avenue Yonkers, NY 10701 Dear Dennis: We are pleased to inform you that both the Board of Directors and management team of Memory Pharmaceuticals Corp. (the "Company") are impressed with your experience and accomplishments, and would like to extend an offer to you to join our Company as Chief Financial Officer. We look forward to you joining our team, and are confident that you will contribute significantly to the value of our organization. We are therefore pleased to provide you with the terms of your anticipated employment by the Company. 1. Position. In your position of Chief Financial Officer you will initially report to the Company's Chief Executive Officer, based out of the Company's offices currently located in Montvale, New Jersey. As Chief Financial Officer, you will be part of the senior management team (comprising the senior executives of the Company), and your responsibilities shall include, but not be limited to, managing and directing the financial affairs of the Company. In addition to performing duties and responsibilities associated with the position of Chief Financial Officer, from time to time the Company may assign you other duties and responsibilities and/or may assign you to a different location within fifty (50) miles of the Company's principal office in Montvale, New Jersey. As a full-time employee of the Company, you will be expected to devote your full business time and energies to the business and affairs of the Company. Your performance will be reviewed formally after six months of employment and 272208	Memory Pharma Memory Pharmaceuticals Corp. ( Pharmaceutical Preparations ) As referenced in this Letter Agreement: [MEMORY PHARMACEUTICALS CORP – {DOCUMENT} {TYPE}EX-10.25 {SEQUENCE}6 {FILENAME}y92465a1exv10w25.txt {DESCRIPTION}EMPLOYMENT LETTER AGREEMENT {TEXT} {PAGE} EXHIBIT 10.25 [MEMORY PHARMACEUTICALS CORP . LOGO] MEMORY PHARMACEUTICALS CORP. Tony Scullion 100 Philips Parkway Chief Executive Officer Montvale, New Jersey 07645 Phone: (201) 802-7102 Fax: (201) _____________ MEMORY PHARMACEUTICALS CORP – DOCUMENT} {TYPE}EX-10.25 {SEQUENCE}6 {FILENAME}y92465a1exv10w25.txt {DESCRIPTION}EMPLOYMENT LETTER AGREEMENT {TEXT} {PAGE} EXHIBIT 10.25 [MEMORY PHARMACEUTICALS CORP. LOGO] MEMORY PHARMACEUTICALS CORP . Tony Scullion 100 Philips Parkway Chief Executive Officer Montvale, New Jersey 07645 Phone: (201) 802-7102 Fax: (201) 802-7190 www.memorypharma. _____________ Memory Pharmaceuticals Corp – Constant Avenue Yonkers, NY 10701 Dear Dennis: We are pleased to inform you that both the Board of Directors and management team of Memory Pharmaceuticals Corp . (the "Company") are impressed with your experience and accomplishments, and would like to extend an offer to you to join our Company _____________ Memory Pharmaceuticals Corp – value to be determined by the Company's Board of Directors (currently $0.90 per share), 300,000 Shares of Common Stock of Memory Pharmaceuticals Corp ., which shall vest in quarterly increments over a period of four (4) years as described in the Stock Option Agreement, which you _____________ MEMORY PHARMACEUTICALS CORP – you will make a significant contribution to the Company's growth. We look forward to your prompt response to this offer letter. Sincerely, MEMORY PHARMACEUTICALS CORP . By: /s/ Tony Scullion ---------------------- Name: Tony Scullion Title: Chief Executive Officer ACCEPTED AND AGREED: /s/ Dennis Keane -------------------------- Dennis Keane Date: 12/16/ _____________ dt 181263
Preview Full Doc	2004	Letter Agreement Letter Agreement (6K) Doc #288856: Click preview link for longer preview. [Letterhead of Critical Therapeutics, Inc.] August 26, 2003 Rick Finnegan 409 Lincoln Rd. Sudbury, MA 01776 Dear Rick: It is my pleasure to offer you the position of Vice President of Sales and Marketing at Critical Therapeutics, Inc. (the "Company"). As you know, I am excited about the contributions that I expect you will make to the success of the Company. Accordingly, if you accept this offer, I would like us to agree that you could start at Critical Therapeutics, Inc. on September 8, 2003 (the "Start Date"). This offer may be accepted by you by countersigning where indicated at the end of this letter on or before September 2, 2003. Duties and Extent of Service As Vice President of Sales and Marketing, you will have responsibility for performing those duties as are customary for, and are consistent with, such position, as well as those duties as I may from time to time designate. You will report to me. As you know, your employment will be contingent upon your agreeing to abide by the rules, regulations, instructions, personnel practices, and policies of the Company and any changes therein that the Company may adopt from time to time, and your execution of the Company's standard Nondisclosure, Developments, and Non-Competition Agreement. Compensation In consideration of your employment with the Company, the Company will pay you a base salary of $220,000 per year, payable in accordance with the Company's standard payroll practices. You will also be eligible for a pro-rated performance based year end bonus of up to 20% of your annual salary plus stock options of up to 50,000. You will receive a sign on bonus of $30,000 payable with your first paycheck. 288856	CTI Critical Therapeutics, Inc. ( Pharmaceutical Preparations ) As referenced in this Letter Agreement: Critical Therapeutics, – EX-10.23 {SEQUENCE}26 {FILENAME}b49788ctexv10w23.txt {DESCRIPTION}EX-10.23 EMPLOYMENT LETTER RICK FINNEGAN {TEXT} {PAGE} Exhibit 10.23 [Letterhead of Critical Therapeutics, Inc.] August 26, 2003 Rick Finnegan 409 Lincoln Rd. Sudbury, MA 01776 Dear Rick: It is my pleasure to offer you the _____________ Critical Therapeutics, – Rd. Sudbury, MA 01776 Dear Rick: It is my pleasure to offer you the position of Vice President of Sales and Marketing at Critical Therapeutics, Inc. (the "Company"). As you know, I am excited about the contributions that I expect you will make to the success of _____________ Critical Therapeutics, – to the success of the Company. Accordingly, if you accept this offer, I would like us to agree that you could start at Critical Therapeutics, Inc. on September 8, 2003 (the "Start Date"). This offer may be accepted by you by countersigning where indicated at the end _____________ dt 238714
Preview Full Doc	2004	Letter Agreement Re: Offer of Employment at Corcept Therapeutics, Inc. Letter Agreement Re: Offer of Employment at Corcept Therapeutics, Inc. (12K) Doc #289279: Click preview link for longer preview. [CORCEPT THERAPEUTICS, INC. LETTERHEAD] October 18, 2001 Dr. Robert L. Roe, M.D. c/o Corcept Therapeutics Incorporated 275 Middlefield Road Menlo Park, CA 94025 Re: Offer of employment at Corcept Therapeutics, Inc. Dear Bob: On behalf of Jim Wilson and our entire Board of Directors, I am pleased to invite you to join the executive team of Corcept Therapeutics, Inc. ("Corcept"). Your initial assignment will be as President, to serve at the pleasure of the Board with primary responsibility for managing our ongoing development programs. Corcept has already achieved several important milestones including the allowance and issuance of key patents, the successful completion of our Phase II PMD trial, the raising of $27,000,000, the designation as a fast-track program by the FDA and the successful start to our Phase III trials. Your vast experience in development will prove invaluable to Corcept as we develop and market drugs for psychotic major depression, dementia, mild cognitive impairment and other serious medical illnesses. In your role as President of Corcept, our PMD Program Director, our Medical Director and others will report to you. We expect that you will also provide input into decisions regarding strategic and market planning, organization development and staffing and that you will help with our intellectual property planning and execution. We also would like your input regarding Corcept's benefit package. You shall, in accordance with Corcept's policies, be eligible to participate in and be covered by any benefit plans or arrangement made available now or in the future to {PAGE} Corcept's key management employees. You will receive four (4) weeks of vacation annually, accrued on a monthly basis beginning on your date of hire. Upon commencement of employment with Corcept pursuant to this letter agreement, you will be granted a stock option to purchase 250,000 shares of the common stock of Corcept (the "Option") under Corcept's Stock Option Plan. The exercise price per share of the Option will be the fair market value of the common stock, as established by the Board of Directors on your hire date; most recently, options on our common stock have been granted at $.75 per share. Subject to the provisions of the Plan, the shares of common stock subject to your Option will be immediately exercisable, subject to a right of repurchase in favor of the Company that will lapse in monthly increments over five (5) years so long as you continue to be employed with Corcept. Corcept agrees that if you elect to exercise the Option, Corcept will loan you an amount equal to the exercise price of the Option. The loan will be secured by the Option stock and a full-recourse demand note, and bear interest (set at a competitive market interest rate when the funds are delivered) compounded monthly and payable in arrears. The outstanding principal and interest shall be due and payable in full upon the earlier of (i) October 1, 2011, (ii) the date 289279	Corcept Corcept Therapeutics Inc. ( Pharmaceutical Preparations ) As referenced in this Letter Agreement Re: Offer of Employment at Corcept Therapeutics, Inc.: [CORCEPT THERAPEUTICS, – 8 {FILENAME}dex102.txt {DESCRIPTION}EMPLOYMENT OFFER LETTER TO ROBERT L. ROE, M.D., DATED OCTOBER 18, 2001 {TEXT} {PAGE} EXHIBIT 10.2 [CORCEPT THERAPEUTICS, INC. LETTERHEAD] October 18, 2001 Dr. Robert L. Roe, M.D. c/o Corcept Therapeutics Incorporated 275 Middlefield Road Menlo Park, CA _____________ Corcept Therapeutics – OCTOBER 18, 2001 {TEXT} {PAGE} EXHIBIT 10.2 [CORCEPT THERAPEUTICS, INC. LETTERHEAD] October 18, 2001 Dr. Robert L. Roe, M.D. c/o Corcept Therapeutics Incorporated 275 Middlefield Road Menlo Park, CA 94025 Re: Offer of employment at Corcept Therapeutics, Inc. Dear Bob: On behalf of Jim Wilson _____________ Corcept Therapeutics, – Dr. Robert L. Roe, M.D. c/o Corcept Therapeutics Incorporated 275 Middlefield Road Menlo Park, CA 94025 Re: Offer of employment at Corcept Therapeutics, Inc. Dear Bob: On behalf of Jim Wilson and our entire Board of Directors, I am pleased to invite you to join _____________ Corcept Therapeutics, – On behalf of Jim Wilson and our entire Board of Directors, I am pleased to invite you to join the executive team of Corcept Therapeutics, Inc. ("Corcept"). Your initial assignment will be as President, to serve at the pleasure of the Board with primary responsibility for managing _____________ Corcept Therapeutics – below. Sincerely, /s/ Joseph K. Belanoff, M.D. ---------------------------------- Joseph K. Belanoff, M.D. Chief Executive Officer I accept the offer of employment by Corcept Therapeutics on the terms described in this letter. Signature: /s/ Robert L. Roe ------------------ Date: 18 October 2001 ---------------- {PAGE} Appendix to Offer of employment dated _____________ dt 238337
Full Doc	2004	Employment Offer Employment Offer (3K) Doc #320758: This document is immediately available for purchase, but does not have a preview available for viewing. 320758	PFI Pharmaceutical Formulations Inc. ( Pharmaceutical Preparations ) As referenced in this Employment Offer: PHARMACEUTICAL FORMULATIONS, INC – Ex-10.1 EX-10 2 pfi-ex101_051804.htm EX-10.1 Exhibiti 10.1 PHARMACEUTICAL FORMULATIONS, INC . 460 PLAINFIELD AVE., EDISON, NJ 08818 TEL (732) 985-7100o FAX (732) 819-3390 CHARLES E. LAROSA PRESIDENT AND CHIEF EXECUTIVE OFFICER _____________ dt 588236
Preview Full Doc	2004	Letter Agreement Re: Offer of Employment Letter Agreement Re: Offer of Employment (8K) Doc #328149: Click preview link for longer preview. [QUESTCOR LETTERHEAD] September 2, 2003 Charles J. Casamento Chairman, President & CEO R. Jerald Beers 3260 Whipple Road Union City, CA 94587 Re: Offer of Employment Dear Mr. Beers: Questcor Pharmaceuticals, Inc. (the "Company") is pleased to offer you the position of Vice President, Marketing, a corporate officer, on the terms described below. Should you accept our offer of employment, your start date will be September 15, 2003. You will report to Charles J. Casamento, Chief Executive Officer. Your office will be located at our facility in Union City, California. Of course, the Company may change your reporting responsibilities, position, duties, and work location from time to time, as it deems necessary. Your base compensation will be $184,000 per annum ($7,666.66 semi-monthly) less all amounts the Company is required to hold under applicable laws. Effective January 1, 2004, you will be a participant in the annual management incentive program for executives, which has been approved by the Compensation Committee. Your incentive bonus will be based on the attainment of specific milestones during each calendar year. The milestones will be communicated to you in writing by Mr. Casamento following the start of your employment and will be updated annually as part of the performance review process. Your maximum bonus opportunity will be 33% of your base compensation earnings in the calendar year to which it applies. The Company will provide you a relocation allowance of an amount not to exceed $75,000, to cover all reasonable and customary expenses associated with your relocation to the San Francisco Bay area. Those expenses paid by you which affect your income tax liability will be "grossed-up" 328149	Questcor Pharma Questcor Pharmaceuticals Inc. ( Pharmaceutical Preparations ) As referenced in this Letter Agreement Re: Offer of Employment: Questcor Pharmaceuticals, – Charles J. Casamento Chairman, President & CEO R. Jerald Beers 3260 Whipple Road Union City, CA 94587 Re: Offer of Employment Dear Mr. Beers: Questcor Pharmaceuticals, Inc. (the "Company") is pleased to offer you the position of Vice President, Marketing, a corporate officer, on the terms described below. _____________ dt 686548
Preview Full Doc	2004	Letter Agreement Letter Agreement (2K) Doc #361267: Click preview link for longer preview. [Pixar Letterhead] January 23, 2003 Ms. Lois Scali 1212 North Tigertail Road Los Angeles, California 90049 Dear Lois: It is with great pleasure that Pixar offers you the position of Executive 361267	Pixar Pixar ( Motion Pictures ) As referenced in this Letter Agreement: [Pixar – {DOCUMENT} {TYPE}EX-10.7 {SEQUENCE}3 {FILENAME}f97250exv10w7.txt {DESCRIPTION}EXHIBIT 10.7 {TEXT} {PAGE} EXHIBIT 10.7 [Pixar Letterhead] January 23, 2003 Ms. Lois Scali 1212 North Tigertail Road Los Angeles, California 90049 Dear Lois: It is with great pleasure that Pixar offers you the position of Executive _____________ Pixar – 7 {TEXT} {PAGE} EXHIBIT 10.7 [Pixar Letterhead] January 23, 2003 Ms. Lois Scali 1212 North Tigertail Road Los Angeles, California 90049 Dear Lois: It is with great pleasure that Pixar offers you the position of Executive Vice-President and General Counsel. It's expected that your start date would be on or before April 1, 2003. Your annual salary will _____________ Pixar – and General Counsel. It's expected that your start date would be on or before April 1, 2003. Your annual salary will be $436,000 paid on a weekly basis. Pixar will grant you a Non-statutory Stock Option to purchase 300,000 shares of Pixar Common Stock, subject to approval by Pixar's Board of Directors and to the terms _____________ Pixar – April 1, 2003. Your annual salary will be $436,000 paid on a weekly basis. Pixar will grant you a Non-statutory Stock Option to purchase 300,000 shares of Pixar Common Stock, subject to approval by Pixar's Board of Directors and to the terms of Pixar's Stock Plan and Option Agreement. The option price will be Pixar's _____________ Pixar' – be $436,000 paid on a weekly basis. Pixar will grant you a Non-statutory Stock Option to purchase 300,000 shares of Pixar Common Stock, subject to approval by Pixar' s Board of Directors and to the terms of Pixar's Stock Plan and Option Agreement. The option price will be Pixar's closing stock price as quoted in The _____________ dt 1391964
Preview Full Doc	2004	Letter Agreement Letter Agreement (5K) Doc #402595: Click preview link for longer preview. June 16, 2003 Vincent J. Miles 62 Woodchester Drive Chestnut Hills, MA 0246' Dear Dr. Miles: I am pleased to offer you the position of Senior Vice President Business Development, Alnylam Pharmaceuticals, Inc., reporting to me. You will receive a semi-monthly salary of $9,791.67, which is equivalent to $235,000.08 annually. You will also be eligible for a bonus opportunity of up to 25% of your base salary. Your bonus, which will be tied to corporate goals and approved by the Board of Directors, will be paid after the conclusion of the fiscal year. Additional program details will be provided during your first 30 days of employment. In addition you will receive a one-time payment in the amount of $25,000, which will be paid after your first 30 days of employment. In the event that you leave Alnylam within the first 18 months of your employment you will be required to pay the company back the full amount of this one time payment. All payments will be subject to legally required tax withholding. You will be granted a stock option to purchase 150,000 shares of the company's Common stock, subject to Board of Directors approval. This option, which currently has an exercise price of $0.25 per share, will be subject to the standard terms and conditions of the Alnylam Stock Option Plan and will be issued soon after you begin employment with the Company. The option will vest over four years at the rate of 25% after twelve months of full time active employment and then an additional 6.25% for each additional quarter of full time active employment until after four full years when the option is fully vested. 402595	Alnylam Pharma Alnylam Pharmaceuticals, Inc. ( Pharmaceutical Preparations ) As referenced in this Letter Agreement: Alnylam Pharmaceuticals, Inc – June 16, 2003 Vincent J. Miles 62 Woodchester Drive Chestnut Hills, MA 0246' Dear Dr. Miles: I am pleased to offer you the position of Senior Vice President Business Development, Alnylam Pharmaceuticals, Inc ., reporting to me. You will receive a semi-monthly salary of $9,791.67, which is equivalent to $235,000.08 annually. You will also be eligible for a _____________ Alnylam Pharmaceuticals, Inc – 202 Cambridge, MA 02139 617-252-0700 {PAGE} Very truly yours, /s/ John M. Maraganore John M. Maraganore President and Chief Executive Officer I accept this offer of employment with Alnylam Pharmaceuticals, Inc . and plan to begin work on July 21, 2003. Signature: /s/ Vincent J. Miles 7/14/2003 --------------------------------- ----------------------- Vincent J. Miles, Ph.D. Date 790 Memorial Drive Suite 202 Cambridge, _____________ dt 1399755

Page 1 of 81 2 3 4 5 6 7 8

Your cart is empty.

Employment Offers

Subscriptions

Services